How Can Biosimilars Capture Market Share From Biologic Drugs?

Biologic drugs, made from living organisms and usually taken by injection or infusion, are expensive treatments for complex chronic conditions such as cancer and autoimmune diseases. Biosimilars, clinically comparable to biologics and priced lower, create cost-saving opportunities for patients and plan sponsors. Many hoped that biosimilars would quickly gain ground once they entered the market. However, the reality has…